Natixis’s COSCIENS Biopharma CSCI Stock Holding History
Bought
Maintained
Sold
Other funds holding CSCI
Natixis's CSCI Position: Q4 2021 in Review
Natixis sold out of COSCIENS Biopharma (CSCI) in Q4 2021, closing a stake of 2,938 shares — an estimated $220K sold.
Natixis first reported a position in CSCI in Q2 2021 and held it in 2 quarters. The position peaked at $220K in Q3 2021. 29 funds tracked by Wall St. Rank hold CSCI as of Q4 2021.
- Natixis reported no remaining COSCIENS Biopharma position as of Q4 2021 after selling out during the quarter.
- Natixis sold 2,938 COSCIENS Biopharma shares in Q4 2021, an estimated $220K.
- Natixis first reported a position in COSCIENS Biopharma in Q2 2021 and held it in 2 quarters.
- Natixis's COSCIENS Biopharma position peaked at $220K in Q3 2021.
- 29 funds tracked by Wall St. Rank held COSCIENS Biopharma as of Q4 2021.
Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.